Published in Neuroepidemiology on June 26, 2009
Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (N Y) (2013) 1.02
Utility of the hand-drawn spiral as a tool in clinical-epidemiological research on essential tremor: data from four essential tremor cohorts. Neuroepidemiology (2015) 1.00
Prevalence of essential tremor in Araihazar, Bangladesh: a population-based study. Neuroepidemiology (2011) 0.85
Late-onset primary dystonia in Zhejiang province of China: a service-based epidemiological study. Neurol Sci (2015) 0.81
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins. Neuropsychiatr Dis Treat (2011) 0.80
Botulinum toxin clinic-based epidemiologic survey of adults with primary dystonia in East china. J Mov Disord (2012) 0.75
Sonographic Alteration of Basal Ganglia in Different Forms of Primary Focal Dystonia: A Cross-sectional Study. Chin Med J (Engl) (2016) 0.75
Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16
Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med (2008) 4.98
Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 4.63
Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol (2010) 3.70
Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia (2011) 3.48
Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry (2009) 3.35
Primary prevention of stroke by healthy lifestyle. Circulation (2008) 3.32
Gout and risk of Parkinson disease: a prospective study. Neurology (2007) 3.09
A prospective cohort study of cancer incidence following the diagnosis of Parkinson's disease. Cancer Epidemiol Biomarkers Prev (2007) 2.77
Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler (2009) 2.63
Migraine and risk of cardiovascular disease in men. Arch Intern Med (2007) 2.49
Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 2.48
Depression and incident stroke in women. Stroke (2011) 2.47
Migraine frequency and risk of cardiovascular disease in women. Neurology (2009) 2.47
Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care (2007) 2.33
Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache (2007) 2.31
Movement-related changes in synchronization in the human basal ganglia. Brain (2002) 2.15
Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia (2011) 2.04
Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ (2008) 2.01
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. Lancet Neurol (2012) 1.95
Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology (2008) 1.90
Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up. J Neurol Sci (2003) 1.81
Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy. J Am Coll Cardiol (2003) 1.72
The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta (2006) 1.72
Dietary flavonoids and risk of stroke in women. Stroke (2012) 1.71
Combined analysis of risk factors for SUDEP. Epilepsia (2011) 1.71
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain (2012) 1.67
Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr (2007) 1.57
Modeling drop-outs in amyotrophic lateral sclerosis. Contemp Clin Trials (2011) 1.53
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int (2013) 1.52
Cigarette smoking and the progression of multiple sclerosis. Brain (2005) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Treatment of first tonic-clonic seizure does not affect mortality: long-term follow-up of a randomised clinical trial. J Neurol Neurosurg Psychiatry (2011) 1.51
Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology (2009) 1.48
ALS and military service. Neurology (2005) 1.44
Distinct cytokine patterns associated with different forms of chronic dysimmune neuropathy. Muscle Nerve (2010) 1.41
Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci (2003) 1.37
Refractory status epilepticus: a prospective observational study. Epilepsia (2009) 1.35
First seizure definitions and worldwide incidence and mortality. Epilepsia (2008) 1.34
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J Neurol (2012) 1.34
Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol (2005) 1.31
Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy. J Neurol (2008) 1.31
Cluster headache prevalence in the Italian general population. Neurology (2005) 1.28
Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology (2010) 1.24
Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Diabetes Care (2008) 1.24
Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol (2011) 1.23
Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2010) 1.22
Coffee consumption and risk of stroke in women. Circulation (2009) 1.22
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology (2006) 1.21
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia (2007) 1.19
Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am J Epidemiol (2011) 1.18
Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy (2012) 1.18
Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study. Amyotroph Lateral Scler (2010) 1.17
Erectile function and risk of Parkinson's disease. Am J Epidemiol (2007) 1.15
Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study. Epilepsia (2004) 1.15
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging (2012) 1.13
Treatment of the first tonic-clonic seizure does not affect long-term remission of epilepsy. Neurology (2006) 1.10
Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease. Cancer Causes Control (2007) 1.09
A clinical score for prognosis of status epilepticus in adults. Neurology (2006) 1.08
Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging (2005) 1.08
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry (2012) 1.08
Treatment of convulsive status epilepticus in childhood: recommendations of the Italian League Against Epilepsy. Epilepsia (2013) 1.07
Should antiepileptic drugs be withdrawn in seizure-free patients? CNS Drugs (2004) 1.05
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study. Orphanet J Rare Dis (2012) 1.05
Barriers toward epilepsy surgery. A survey among practicing neurologists. Epilepsia (2011) 1.05
Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci (2007) 1.05
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option? Expert Opin Investig Drugs (2011) 1.04
Epilepsy and quality of life in adults: a review of instruments. Epilepsy Res (2005) 1.03
Comment on epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia (2005) 1.03
Cross-country measures for monitoring epilepsy care. Epilepsia (2007) 1.03
Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev Neurother (2011) 1.03
Utilisation of Healthcare and Associated Services in Huntington's disease: a data mining study. PLoS Curr (2011) 1.02
Multicenter study of peroneal mononeuropathy: clinical, neurophysiologic, and quality of life assessment. J Peripher Nerv Syst (2005) 1.01
Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis (2013) 1.01
Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci (2006) 1.01
Health-related quality of life and disability in young patients with spina bifida. Arch Phys Med Rehabil (2002) 1.01
Rare missense variants of neuronal nicotinic acetylcholine receptor altering receptor function are associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet (2009) 1.01
Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol (2014) 0.99
Learning disorders in epilepsy. Epilepsia (2006) 0.99
Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology (2012) 0.99
The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler (2010) 0.99
A prospective study of alcoholism and the risk of Parkinson's disease. J Neurol (2004) 0.98
Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. J Peripher Nerv Syst (2008) 0.97
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. Expert Rev Neurother (2014) 0.97
The administration of rescue medication to children with prolonged acute convulsive seizures in the community: what happens in practice? Eur J Paediatr Neurol (2012) 0.96
The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure. Curr Med Chem (2007) 0.96
Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study. Clin Rehabil (2007) 0.96
The first seizure and its management in adults and children. BMJ (2006) 0.96
Medical risks in epilepsy: a review with focus on physical injuries, mortality, traffic accidents and their prevention. Epilepsy Res (2004) 0.96
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease? Curr Opin Psychiatry (2014) 0.96